The manufacturing records for the onxane-25 serial number sn(b)(4) were reviewed and it was confirmed that all records were controlled, available for review, and met all specifications per the device master record.All lots passed functional testing and met release specifications.During the investigation no non-conformances or deviations were noted.The onxane-25 sn (b)(4) was implanted (b)(6)2018 in the aortic position of a 54 year old male.The surgeon sized for a 25mm valve, but had trouble making the valve fit, tearing and patching the aorta in the process.The surgeon feels the sizer misrepresents the valve, in particular that the valve is larger than the sizer.The "yellow" sizer is from instrument set model onxl3.Contrary to the surgeon's feeling, the sizer for onxl3 is actually larger than the valve by a small amount to help prevent oversizing.We don't have any more details of the operation, but the most likely scenario is that the surgeon sized the native annulus, then placed the sutures, and then tried to lower the valve into place without first re-checking the fit with the sizer.The suture line (depending upon type and technique) can have a cinching effect on an annulus, effectively reducing the annulus diameter.Forcing the valve in to the point of aortic rupture strongly hints at oversizing.The instructions for use caution against oversizing and recommends a "comfortable fit" [ifu].This is a case of inappropriate valve sizing, most likely related to surgical technique and not related to valve (or sizer) performance.Surgeon training/retraining on sizing technique may be appropriate.This report is being submitted as required by federal regulations and does not constitute an admission that the device caused or contributed to the reported event.Furthermore, this report reflects the event as alleged by the complainant and does not imply that the information reported to cryolife is accurate or has been confirmed by cryolife.
|